UNITEDHEALTH GROUP INC
UnitedHealth Group is a health care and well-being company serving patients, consumers, care providers, businesses, communities and governments. It operates two complementary businesses, Optum and UnitedHealthcare, across four reportable segments: Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. Optum Health provides care, care management, wellness services and health financial services. Optum Insight offers data, analytics, research, consulting, technology and managed services. Optum Rx provides pharmacy care services. UnitedHealthcare offers health benefits to employers, individuals, seniors and Medicare-eligible consumers, and people served by state health programs. UnitedHealth Group makes money through health benefit premiums, fees for administering or managing products and services, and contracted fees for health-related products and medical services. Optum Health also has arrangements in which it assumes health care costs in exchange for a monthly premium, while Optum Financial charges fees and earns investment and interest income on managed funds and loans. UnitedHealthcare is headquartered in Eden Prairie, Minnesota.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $UNH in the last 30 days.
See all $UNH insider activity →Sen. Elizabeth Warren criticized UnitedHealth's $3.3B Amedisys acquisition, proposing the Break Up Big Medicine Act to separate insurers from providers. Analysts expect UnitedHealth's EPS to recover to $23.29 by 2027, but political pressure may cap its stock multiple. The company's stock trades at 18x forward earnings, below its 5-year average.
Humana (HUM) gained 16.5% after its Medicare Advantage plan improved to four stars, restoring federal bonus eligibility. Analysts expect $4.8B in bonuses in 2028. UnitedHealth (UNH) and CVS (CVS) saw declines in four-star-plus plan memberships. Humana's 2027 EPS is projected to rebound to $17.31 after a 47% drop in 2026.
UnitedHealth Group's stock dropped 4% in after-hours trading, reducing its market value by $14 billion. The largest U.S. health insurer, with a market cap of $355.6 billion, saw significant decline, closing below the $400 threshold, which may influence near-term sentiment. The sell-off was gradual and sustained, indicating broad pressure.
Over the past 7 days, AlphAI's AI scored 26 news stories mentioning UNH (UNITEDHEALTH GROUP INC). Coverage has skewed bullish: 12 bullish, 6 neutral, and 8 bearish.
Recent UNH coverage spans market movers, financial news and earnings.
Legislative risk could cap the multiple and shift valuation toward near-term earnings recovery rather than structural optionality.
UnitedHealth may face downward pressure as its share of high‑rated plans declines.
The sharp drop suggests continued selling pressure and a test of the $400 support level.
ETF adds demand for UNH.
Limited new impact as the earnings data is already public.
AlphAI scores every news story that mentions UNH with an AI model for sentiment and relevance, and aggregates insider trades from UNITEDHEALTH GROUP INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Sen. Elizabeth Warren criticized UnitedHealth's $3.3B Amedisys acquisition, proposing the Break Up Big Medicine Act to separate insurers from providers. Analysts expect UnitedHealth's EPS to recover to $23.29 by 2027, but political pressure may cap its stock multiple. The company's stock trades at 18x forward earnings, below its 5-year average.
Humana (HUM) gained 16.5% after its Medicare Advantage plan improved to four stars, restoring federal bonus eligibility. Analysts expect $4.8B in bonuses in 2028. UnitedHealth (UNH) and CVS (CVS) saw declines in four-star-plus plan memberships. Humana's 2027 EPS is projected to rebound to $17.31 after a 47% drop in 2026.
UnitedHealth Group's stock dropped 4% in after-hours trading, reducing its market value by $14 billion. The largest U.S. health insurer, with a market cap of $355.6 billion, saw significant decline, closing below the $400 threshold, which may influence near-term sentiment. The sell-off was gradual and sustained, indicating broad pressure.
State Street Health Care Select Sector SPDR ETF (XLV) bought $330.3M in stocks on Nov. 3, increasing all 60 holdings. Top purchases included Eli Lilly (LLY) at $56.0M, Johnson & Johnson (JNJ) at $31.8M, and AbbVie (ABBV) at $25.1M. XLV has $49.13B in assets and a 0.08% expense ratio.
UnitedHealth (UNH) reported Q3 adjusted EPS of $4.69 and raised its 2026 EPS floor to at least $20.50, showing expense discipline. However, commercial and Medicaid trends remain pressured, and an IRS case is unresolved. Analysts highlight three other companies trading below their estimates, targeting kidney diseases, data center connectivity, and hyperscale data center systems.
UnitedHealth Group (UNH) shares rose 4.2% to $411.60, adding $15 billion to its market value, following CVS's better-than-expected Q3 earnings. The results boosted sentiment in the managed-care sector, with investors reassessing the industry's near-term outlook.
UnitedHealth Group's board approved a $2.32 per share quarterly dividend, payable Dec 15, 2026. Q3 2026 earnings rose to $4.56 per share, with revenue at $112.7B. The company raised its 2026 outlook to $19.50 GAAP EPS and $20.50 adjusted EPS. UNH shares are down 0.57% at $401.2.
Union Bancaire Privee, UBP SA opened a $11.4M position in UnitedHealth Group (UNH) according to a recent SEC 13F filing. Several other institutional investors also adjusted their UNH holdings, with notable additions from JPMorgan Chase and Sixth Street Partners. Analysts have set various price targets for UNH, with a median of $462.0.
UnitedHealth Group expanded its share buyback authorization by 50 million shares, set to expire in November 2026. This is in addition to shares remaining under the 2024 program renewal, according to the company.
UnitedHealth Group (UNH) stock rose 11% in October, driven by strong Q3 earnings and an improved 2026 profit outlook. Adjusted EPS was $4.69, beating estimates, while revenue slightly declined to $112.7B. Optum Health's profit grew, but insurance membership remains a concern. Analysts see potential upside with shares trading at 18x forward earnings.
